ACLS
Company Description
Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semiconductor chips. Operating internationally, its presence extends across North America, Europe, and Asia. The firm offers a wide array of implanter technologies, such as high-energy, high-current, and medium-current systems, designed to meet diverse application needs. Furthermore, Axcelis provides extensive post-sales support and lifecycle solutions, including the sale of pre-owned equipment, replacement parts, system upgrades, ongoing maintenance, and client instruction. It directly furnishes its advanced equipment and services to microchip manufacturers through its own dedicated sales personnel. Founded in 1978, Axcelis Technologies has its corporate headquarters situated in Beverly, Massachusetts.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 839.05M | 1.02B | 1.13B | 920.00M | 662.43M | 474.56M | 342.96M | 442.57M | 410.56M | 266.98M | 301.50M | 203.05M |
| Net Income | 120.24M | 200.99M | 246.26M | 183.08M | 98.65M | 49.98M | 17.03M | 45.88M | 126.96M | 11.00M | 14.68M | (11.27M) |
| EPS | 3.81 | 6.17 | 7.52 | 5.54 | 2.94 | 1.50 | 0.52 | 1.35 | 4.11 | 0.38 | 0.52 | -0.40 |
| Free Cash Flow | 107.01M | 128.64M | 136.21M | 204.92M | 141.47M | 62.27M | (25.56M) | 42.25M | 49.00M | (11.30M) | 16.43M | (17.07M) |
| FCF / Share | 3.39 | 3.95 | 4.16 | 6.20 | 4.22 | 1.87 | -0.79 | 1.24 | 1.59 | -0.39 | 0.57 | -0.61 |
| Operating CF | 118.31M | 140.82M | 156.87M | 215.61M | 150.19M | 69.70M | (13.59M) | 46.97M | 56.28M | (8.80M) | 18.26M | (16.05M) |
| Total Assets | 1.36B | 1.35B | 1.28B | 1.01B | 753.24M | 624.62M | 548.09M | 548.44M | 488.22M | 302.23M | 288.28M | 227.65M |
| Total Debt | 42.33M | 43.67M | 45.19M | 46.41M | 47.39M | 48.15M | 48.55M | 47.76M | 47.71M | 47.59M | 47.59M | 14.53M |
| Cash & Equiv | 145.45M | 123.51M | 167.30M | 185.59M | 294.92M | 203.48M | 139.88M | 177.99M | 133.41M | 70.79M | 78.89M | 30.75M |
| Book Value | 1.03B | 1.01B | 864.88M | 667.26M | 538.96M | 481.60M | 419.43M | 408.34M | 353.61M | 201.46M | 190.26M | 168.35M |
| Return on Equity | 0.12 | 0.20 | 0.28 | 0.27 | 0.18 | 0.10 | 0.04 | 0.11 | 0.36 | 0.05 | 0.08 | -0.07 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 198.96M | 238.33M | 213.61M | 194.54M | 192.56M | 252.42M | 256.56M | 256.51M | 252.37M | 310.29M | 292.33M | 273.97M |
| Net Income | 9.21M | 34.30M | 25.99M | 31.38M | 28.58M | 49.96M | 48.58M | 50.87M | 51.59M | 71.06M | 65.93M | 61.58M |
| EPS | 0.30 | 1.11 | 0.83 | 0.98 | 0.89 | 1.54 | 1.49 | 1.56 | 1.58 | 2.17 | 2.01 | 1.88 |
| Free Cash Flow | 16.30M | (8.90M) | 43.34M | 37.74M | 34.84M | 8.12M | 41.85M | 38.06M | 40.60M | 55.42M | 18.72M | 29.75M |
| FCF / Share | 0.53 | -0.29 | 1.38 | 1.18 | 1.08 | 0.25 | 1.29 | 1.17 | 1.24 | 1.69 | 0.57 | 0.91 |
| Operating CF | 18.14M | (6.57M) | 45.35M | 39.73M | 39.80M | 12.78M | 45.75M | 40.07M | 42.22M | 65.58M | 24.02M | 32.72M |
| Total Assets | 1.37B | 1.36B | 1.35B | 1.32B | 1.34B | 1.35B | 1.34B | 1.29B | 1.31B | 1.28B | 1.20B | 1.12B |
| Total Debt | 41.96M | 42.33M | 42.67M | 43.00M | 43.33M | 43.67M | 44.07M | 44.46M | 44.83M | 45.19M | 45.51M | 45.82M |
| Cash & Equiv | 150.83M | 145.45M | 187.50M | 173.65M | 183.96M | 123.51M | 120.07M | 145.17M | 133.96M | 167.30M | 142.30M | 132.50M |
| Book Value | 1.04B | 1.03B | 1.02B | 1.02B | 1.03B | 1.01B | 975.59M | 934.95M | 901.74M | 864.88M | 800.97M | 744.04M |
| Return on Equity | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.08 |